跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,105 条关于
“Frontier Inflammasome Therapeutics”
全部
17,105
临床试验
3,663
药物
3,132
机构
1,129
资讯
9,181
上个月
Six Australian biomed startups share A$13.5m in CUREator+ funding round
去年
Inflammasome Therapeutics' K8 Implant Shows Promise in Geographic Atrophy Trial
去年
Inflammasome Therapeutics' K8 Implant Reduces Geographic Atrophy Lesion Growth by 53% in Phase I Trial
10个月前
Inflammasome Therapeutics Partners with Mass General's Healey ALS Center to Test Novel Neuroinflammation Drug K9
去年
Halia Therapeutics Completes Enrollment in Phase 2a Trial of Novel NLRP3 Inflammasome Inhibitor for Myelodysplastic Syndrome
9个月前
Zealand Pharma Unveils Metabolic Frontier 2030 Strategy with OTR Therapeutics Partnership
2个月前
Inflammasome Therapeutics' K8 Slows Geographic Atrophy Lesion Growth by 54% and Shows Visual-Acuity Benefit in Phase 2 Trial
5年前
Novel NLRP3 Inflammasome Inhibitors Show Promise for Treating Multiple Inflammatory Diseases
4年前
NEK7 Emerges as Promising Inflammasome Target Despite Novartis Study Raising Questions About Universal Requirement
去年
Fourth Frontier's Frontier X Plus ECG Monitor Receives FDA Clearance
第 1 页，共 919 页
上一页
下一页
